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The role of maternal-speciﬁc H3K9me3
modiﬁcation in establishing imprinted
X-chromosome inactivation and embryogenesis
in mice
Atsushi Fukuda1, Junko Tomikawa2, Takumi Miura1, Kenichiro Hata2, Kazuhiko Nakabayashi2, Kevin Eggan3,
Hidenori Akutsu1 & Akihiro Umezawa1
Maintaining a single active X-chromosome by repressing Xist is crucial for embryonic
development in mice. Although the Xist activator RNF12/RLIM is present as a maternal factor,
maternal Xist (Xm-Xist) is repressed during preimplantation phases to establish imprinted
X-chromosome inactivation (XCI). Here we show, using a highly reproducible chromatin
immunoprecipitation method that facilitates chromatin analysis of preimplantation embryos,
that H3K9me3 is enriched at the Xist promoter region, preventing Xm-Xist activation by
RNF12. The high levels of H3K9me3 at the Xist promoter region are lost in embryonic stem
(ES) cells, and ES-cloned embryos show RNF12-dependent Xist expression. Moreover, lack of
Xm-XCI in the trophectoderm, rather than loss of paternally expressed imprinted genes, is the
primary cause of embryonic lethality in 70–80% of parthenogenotes immediately after
implantation. This study reveals that H3K9me3 is involved in the imprinting that silences
Xm-Xist. Our ﬁndings highlight the role of maternal-speciﬁc H3K9me3 modiﬁcation in
embryo development.
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o maintain proper dosage compensation in mammals, one
of the two X chromosomes in the female is inactivated1,2.
In establishment of X-chromosome inactivation (XCI), a
large non-coding RNA, Xist, is expressed and this non-coding
RNA then covers the entire X chromosome in cis1–3. In mice, two
types of XCI occur during female embryonic development. One
type involves random XCI, which is observed in cells derived
from epiblasts, and one of the two X chromosomes (paternal or
maternal) is randomly inactivated. The other involves imprinted
XCI (iXCI), which is observed in extra-embryonic tissues and
causes XCI of the paternal X chromosome (Xp)4. The initiation of
iXCI begins at early preimplantation in embryos and Xp-Xist is
expressed around the four-cell stage1. A recent study showed that
a maternal factor, the E3 ubiquitin ligase RNF12, is the primary
factor responsible for Xp-Xist activation5. Interestingly, although
RNF12 is abundant as a maternal factor in oocytes, Xm-Xist is
not expressed. Moreover, maternal Xist (Xm-Xist)-speciﬁc
imprints, which are refractory to the Xm-Xist activation
induced by RNF12, are imposed during oogenesis6. Xist
expression analysis using de novo DNA methyltransferase
(Dnmt3a/b) maternal knockout mice demonstrated that Xist
expression during preimplantation is independent of DNA
methylation7, implying that other epigenetic factors are
associated with Xm-Xist silencing. However, the nature of these
Xm-speciﬁc epigenetic modiﬁcations is unknown.
A gene-knockout study demonstrated that loss of Xp-Xist
expression critically affects postimplantation female development
due to lack of iXCI, which causes overexpression of X-linked
genes in extra-embryonic tissues8. Similar to the phenotype
observed in Xp-Xist-knockout mice, parthenogenetic embryos
(PEs) composed of two X chromosomes show increased
expression of X-linked genes, as compared with fertilized
females, because of the low expression of Xist9. One of
the interesting phenomena observed in PEs is the dramatic
developmental failure that occurs immediately after implantation.
Around 70–80% of embryos die before embryonic day (E) 9.5,
which is the limit of development for PEs10. However, it is
unknown whether the primary cause of rapid developmental
failure in postimplantation PEs is the loss of iXCI or the loss of
expression of autosomal paternally imprinted genes11,12.
The global epigenetic asymmetry of parental genomes in
zygotes is retained during early preimplantation phases in mice
and changes in gene expression occur in discrete stages to confer
totipotency13,14. Interestingly, transcriptionally repressive marks,
such as histone H3 lysine 9 di-/trimethylation (H3K9me2/3), are
speciﬁcally imposed on maternal genomes at the zygote stage13.
Although the regulation of imprinted genes mostly depends on
DNA methylation, some imprinted genes are regulated by these
histone modiﬁcations15,16. Thus, Xm-Xist silencing machinery
may be associated with histone modiﬁcations.
Here we reveal that silencing of Xm-Xist in preimplantation
embryos involves modiﬁcation of H3K9me3. By using a new
chromatin immunoprecipitation (ChIP) method that facilitates
chromatin analysis in preimplantation embryos, we show that the
Xist promoter on the Xm is highly enriched for H3K9me3 at the
four-cell stage. This enrichment is lost in the morula and in male
embryonic stem (ES) cells. Furthermore, we demonstrate that
early loss of H3K9me3 at the Xist promoter leads to precocious
Xm-Xist activation in a Rnf12-dependent manner. Moreover, we
demonstrate that establishment of Xm-XCI in the trophectoderm
allows PEs to develop at the postimplantation stage without the
expression of paternally imprinted genes on autosomes. There-
fore, these data indicate that the primary cause of embryonic
lethality immediately after implantation in most PEs is loss of
XCI rather than loss of the expression of paternally imprinted
genes located on autosomes. Our study revealed that silencing of
Xm-Xist by imprinting to establish iXCI involves H3K9me3, and
this ﬁnding is expected to resolve the longstanding issues that
have limited our general understanding of XCI in mice.
Results
Changes in histone modiﬁcations cause Xm-Xist derepression.
Histone repressive marks, such as H3K9me2/3 and H3K27me3,
are speciﬁcally imposed on maternal genomes13. To investigate
the role of maternal-speciﬁc modiﬁcations in imprinted Xist
expression, we focused on Kdm3a and Kdm4b, which encode
histone demethylases speciﬁc for H3K9me1/2 and H3K9me3
(refs 17,18), respectively. Reverse transcription–PCR analysis
showed that oocytes express low levels of Kdm3a and Kdm4b
(Supplementary Fig. 1). Immunoﬂuorescence (IF) analyses
revealed that zygotes injected with polyadenylated Kdm3a and
Kdm4b messenger RNAs expressed signiﬁcantly lower levels of
maternal H3K9me2 and H3K9me3, respectively (Fig. 1a–d).
Ectopic expression of Kdm3a and Kdm4b did not affect
H3K9me3 or H3K9me2 marks, respectively (Supplementary
Fig. 2). We reasoned that if Xm-speciﬁc modiﬁcations that
prevent Xist activation were erased by these epigenetic modiﬁers,
Xm-Xist would be expressed at the four-cell stage, which is when
Xp-Xist expression commences.
To facilitate analysis of Xm-Xist expression, we used PEs
(Fig. 1e). PEs possess two copies of Xm, and Xm-Xist is never
expressed at the four-cell stage19. Xm-Xist expression in four-cell
PEs, cultured for 48h, was determined using quantitative real-
time PCR (qPCR). Consistent with a previous report19, Xm-Xist
was not detectably expressed in most intact (not injected) PEs and
PEs injected with Egfp mRNA (Egfp-PEs; Fig. 1f). Approximately
75% of PEs injected with Kdm3a mRNA (Kdm3a-PEs) did not
detectably express Xist. However, Xm-Xist expression was
detected in all PEs injected with Kdm4b mRNA (Kdm4b-PEs;
Figure 1 | Alterations in histone modiﬁcations derepress Xm-Xist expression. (a–d) Oocytes injected with Kdm3a (a,b), Kdm4b (c,d)o rEgfp mRNAs
were subjected to ICSI. After 7–8h, embryos were ﬁxed and analysed for H3K9me2 (a) and H3K9me3 (c) using IF. Nuclei stained with 40,6-diamidino-2-
phenylindole (DAPI) are shown in blue. Representative images are presented on the left. The box-and-whisker plot shows the ratio of maternal to
paternal signal intensities. The horizontal line indicates the median. The P-values were calculated using the Mann–Whitney U-test (U-test). Pb, polar body;
n, number of embryos analysed (b,d). (e) Schema of the generation of PEs with altered histone modiﬁcations. To examine the effects of histone
demethylation on Xm-Xist expression, either H3K9me2 demethylase (Kdm3a) or H3K9me3 demethylase (Kdm4b) mRNAs were injected into MII
oocytes that were then activated. To assess the effects of inhibition of histone deacetylation on Xm-Xist expression, oocytes were activated and incubated
in the presence of TSA for 24h. After 48h, ten four-cell PEs were pooled and analysed as one biological replicate using qPCR. (f) Analysis of
Xm-Xist expression at the four-cell stage. The expression level of Xm-Xist in female embryos derived from IVF was deﬁned as 1. One or two asterisks
indicate Xm-Xist expression in one or two replicates, respectively. The P-values were determined using Student’s t-tests. Error bars indicate the
mean±s.e.m. (g–i) Xist FISH analysis of Kdm4b- and EgfpþTSA-PEs at the four-cell stage. (g) Representative images of FISH results. (h) Ratio of cells
with Xist signal to the total number of cells. n, number of interphase cells analysed. (i) Ratio of cells with biallelic expression to total cells. The detailed
FISH results are shown in Supplementary Table 1. Scale bars, 20mm.
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derepression.
We next assessed the effects of a histone deacetylase inhibitor,
trichostatin A (TSA), on Xm-Xist expression. TSA-treated PEs
(IntactþTSA-PEs and EgfpþTSA-PEs) also activated Xm-Xist
(Fig. 1f). No signiﬁcant changes were detected in Xm-Xist
expression levels between Kdm4b-PEs and EgfpþTSA-PEs.
However, although co-injection with Kdm4b and Kdm3a mRNAs
did not increase Xm-Xist expression levels as compared with
Kdm4b-PEs, a combination of TSA and Kdm4b-mRNA sig-
niﬁcantly increased Xm-Xist expression as compared with Egfpþ
TSA-PEs (2.9-fold, Po0.04, Student’s t-test; Fig. 1f). Moreover,
derepression of Xm-Xist transcription occurred in the absence of
Rnf12 overexpression (Supplementary Fig. 3), and Jpx and Ftx,
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Figure 2 | Global XCI and Xist expression states of Xm at late preimplantation stages. (a) Analysis of Xist expression using qPCR of individual
embryos in the morula. An asterisk indicates Po0.05 (Student’s t-test) compared with Egfp-PEs. FEs, fertilized embryos. (b) Large-scale qPCR analysis of
Xist and eight X-linked genes in individual blastocysts after culturing for 96h. Coloured bars indicate expression levels. (c,d) IF (H3K27me3, green)
combined with RNA FISH (Xist, red) analysis in 96-h blastocyst stage. 40,6-diamidino-2-phenylindole (DAPI)-stained nuclei are shown in blue.
(c) Representative confocal projection. Scale bars, 50mm. (d) The graph shows Xist expression and H3K27me3 modiﬁcation states in individual
embryos. The horizontal axis indicates the average percentage in the group. *Po3.1 10 28 (Fisher’s exact test). n, number of embryos analysed.
(e,f) Xm-Xist biallelic expression states in PEs at 96h. The asterisk indicates cells with biallelic expression. Scale bars, 20mm. (f) Summary of the ratio
of biallelic cells to Xist-positive cells in 96-h blastocyst stage in each group. The number of cells is shown in Supplementary Table 3. (g) qPCR analysis of
Xist and eight X-linked genes in individual blastocysts after culturing for 120h. (h,i) IF (H3K27me3, green) combined with RNA FISH (Xist, red) analysis in
120h blastocysts. *Po5.4 10 23 (Fisher’s exact test). Scale bars, 50mm. (j) The ratio of biallelic cells to Xist-positive cells in 120h blastocysts.
In qPCR analysis, the average expression level of Xm-Xist in Egfp-PEs was set as 1 (also see the Methods section). Gapdh and b-actin were used as
internal controls. Data are summarized in Supplementary Table 4.
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at the four-cell stage. These results showed that KDM4B- and
TSA-mediated Xm-Xist derepression was not involved in the
abnormal expression of known Xist activators.
Next, we examined Xm-Xist derepression states at the single-
cell level by ﬂuorescence in situ hybridisation (FISH) of Xist
RNA. Consistent with the qPCR results, Xm-Xist signals were
signiﬁcantly increased in EgfpþTSA- and Kdm4b-PEs (Fig. 1g,h
and Supplementary Table 1). However, neither TSA treatment
nor Kdm4b overexpression consistently activated Xm-Xist in all
cells (Fig. 1g,h). FISH analysis also revealed Xist biallelic cells in
Kdm4b- and EgfpþTSA-PEs (Kdm4b-PEs: 34% and EgfpþTSA-
PEs: 13%; Fig. 1g,i). Taken together, these results indicated that
Kdm4b overexpression and TSA treatment induced Xm-Xist
derepression at the same developmental stage as Xp-Xist
activation.
Xm-Xist transcripts establish XCI at the blastocyst stage.T o
investigate whether Xm-Xist transcripts from the four-cell stage
induced XCI in late preimplantation stages, we cultured Kdm4b-,
EgfpþTSA- and Kdm4bþTSA-PEs until the blastocyst stage.
Development into blastocysts occurred in 480% of PEs in all
groups (Supplementary Table 2). At the morula stage (72h),
although Egfp-PEs initiated Xm-Xist expression, the levels of Xist
expression were signiﬁcantly lower compared with those in
Kdm4b-injected and/or TSA-treated PEs (Fig. 2a). At the 96-h
blastocyst stage, we examined the expression levels of Xist and
X-linked genes (Tsix, Rnf12, Pgk1, Fmr1nb, Atrx, Uba1, Mecp2
and Plac1) in individual embryos. The signiﬁcant upregulation of
Xist observed in PEs that had been injected with Kdm4b mRNA
and/or TSA continued in 96-h blastocyst stage (Fig. 2b). In PEs
exhibiting Xm-Xist upregulation, Tsix expression was not
detectable and Rnf12 was not overexpressed as compared with
Egfp-PEs (Fig. 2b). The average expression levels of Pgk1, Plac1
and Fmr1nb in Kdm4b-overexpressing or TSA-treated PE groups
were signiﬁcantly reduced (Supplementary Fig. 4a). However,
single embryos in the same group exhibited heterogeneity in the
expression levels of these targets (Fig. 2b). Moreover, although
Xm-Xist was not overexpressed in Kdm4b-overexpressing or
TSA-treated PE groups compared with levels seen in female
fertilized embryos (FEs), the levels of Plac1 and Pgk1 were
strongly downregulated in Kdm4b-, EgfpþTSA- and Kdm4bþ
TSA groups (Fig. 2b). These results suggested that Xm-Xist
expression states differed at the single-cell level in individual
embryos.
To gain further insights into Xist expression states and
repression of X-linked genes on Xm alleles, we conducted IF to
detect the H3K27me3 state, which is a hallmark of XCI20, and
performed Xist FISH analysis. The Xist RNA FISH probe
recognizes Xist and Tsix. Therefore, the cloud state of the FISH
signal deﬁned Xist expression. Consistent with the qPCR results,
the number of cells with Xist signals increased signiﬁcantly in all
Kdm4b-overexpressing or TSA-treated PEs (Fig. 2c and
Supplementary Table 3). However, in all Kdm4b-overexpressing
or TSA-treated PEs, o45% of Xist cloud-containing cells had an
H3K27me3 signal (Fig. 2c,d and Supplementary Table 3). We also
found that Xist biallelic cells were present in all PE groups
(Egfp-PEs: 2.2%, EgfpþTSA-PEs: 5.9%, Kdm4b-PEs: 9.0% and
Kdm4bþTSA-PEs: 10.3%; Fig. 2e,f). These results suggested that
there were various Xm-Xist expression states present at the
single-cell level, affecting the heterogeneity of X-linked genes, and
that strong suppression of some X-linked genes in Kdm4b-
overexpressing or TSA-treated PEs could be attributed to biallelic
expression of Xm-Xist.
As Kdm4b overexpression and TSA treatment did not affect the
extent of H3K27me3 modiﬁcation (Supplementary Fig. 5), its
acquisition in PEs may have been slightly delayed compared with
that in FEs. In support of this notion, the developmental timing of
PEs lags behind that of FEs9. Therefore, we extended the culture
period to 120h and again performed qPCR, IF and FISH analyses.
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Figure 2 | Continued.
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that Plac1 and Pgk1 were signiﬁcantly repressed in Kdm4b-
overexpressing or TSA-treated PEs, although heterogeneity was
observed (Fig. 2g and Supplementary Fig. 4b). However, Fmr1nb,
which was signiﬁcantly repressed in 96-h blastocyst stage of both
Kdm4b- and TSA-treated groups, did not show marked
suppression (Fig. 2g and Supplementary Fig. 4b), suggesting
that Xist expression states were altered in 120h blastocysts.
In FISH and IF analysis, a signiﬁcant increase in the number of
Xist-positive cells was detected in Kdm4b-overexpressing and/or
TSA-treated PEs, as compared with Egfp-PEs, after culture for
120h (Fig. 2h,i and Supplementary Table 4). There was a marked
increase in the ratio of H3K27me3 spots to cloud Xist signals in
blastocysts in all groups compared with that observed after 96h of
culture as follows: 88.1% in Egfp-PEs, 78.7% in EgfpþTSA-PEs,
91.8% in Kdm4b-PEs and 91.2% in Kdm4bþTSA-PEs (Fig. 2h,i
and Supplementary Table 4). Interestingly, 498% of the cells in
the Xist cloud state exhibited monoallelic Xist expression in all
groups at 120h (Fig. 2j).
Taken together, these results indicated that Kdm4b over-
expression and TSA treatment induced global XCI of Xm in
blastocysts and that the counting mechanism automatically
functioned in late blastocysts, as has also been observed for Xp
alleles21.
KDM4B-mediated Xm-Xist expression depends on RNF12.
During preimplantation phases, Xp-Xist expression is induced by
maternal RNF12 (ref. 5). Thus, we investigated whether Xm-Xist
expression also depended on RNF12. High Rnf12 expression
levels were maintained until the four-cell stage (around 80-fold
higher than in ES cells; Fig. 3a). At the morula stage, although the
expression level was signiﬁcantly decreased compared with that in
oocytes, Rnf12 expression was still more than ninefold higher
than that in ES cells (Fig. 3a), indicating that maternal and early
zygotic RNF12 may be critical for Xm-Xist activation. To examine
the dependency of RNF12 on Xm-Xist expression, we inhibited
maternal and zygotic RNF12 expression using Rnf12-siRNA
(Supplementary Fig. 6a). IF analysis at the one-cell stage
showed a marked decline in RNF12 signal intensity in si-Rnf12
embryos compared with that in the si-control embryos (Fig. 3b).
Signiﬁcant repression by si-Rnf12 was maintained in the
four-cell stage (Supplementary Fig. 6b,c). Using this knockdown
system, we examined whether Xm-Xist activation was induced
by RNF12 at the morula stage. Xist FISH analysis revealed
that Xist signals (cloud and pinpoint) in PEs treated with
si-Rnf12 were signiﬁcantly reduced at the morula stage as
compared with those observed in the controls (si-Rnf12:
50.0% versus si-control: 80.0%; Fig. 3c,d and Supplementary
Table 5).
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four-cell stage by ectopic Kdm4b expression or TSA treatment
was regulated by RNF12 (Supplementary Fig. 6d). Four-cell
embryos of Kdm4b-o rEgfpþTSA-PEs treated with si-Rnf12
were analysed by qPCR. Depletion of RNF12 did not affect Xm-
Xist expression in EgfpþTSA-PEs compared with the si-control
PEs (Fig. 3e), suggesting that factors other than RNF12 may
contribute to histone acetylation-mediated Xm-Xist activation.
This observation is consistent with results obtained using
Rnf12 /  mice, which demonstrated that Xist is activated by
RNF12 and other unidentiﬁed factors5,22. In contrast, Xist
expression in Kdm4b-PEs derived from oocytes treated with
si-Rnf12 did not induce detectable expression of Xm-Xist (Fig. 3f).
These results demonstrated that KDM4B-mediated Xm-Xist
expression depended on RNF12 and suggested that H3K9me3
prevented the expression.
Promoter demethylation of H3K9me3 causes Xm-Xist
derepression. As activation of Xist by RNF12 is essential for
establishing iXCI5, we attempted to determine the mechanism
responsible for the transcriptional derepression of Xm-Xist by
KDM4B-mediated demethylation of H3K9me3. We ﬁrst
examined whether H3K9me3 levels were enriched at the Xp-
Xist promoter region. Nucleosomes were extracted from the
sperm genome (Supplementary Fig. 7). ChIP-qPCR revealed the
low H3K9me3 levels of Xp-Xist in the 50-regions containing the
major promoter for Xist expression (average: 2.1%; Fig. 4a), as
compared with those of the H19, Gtl2, Peg1 and Peg3 promoter
loci (average: 8.5%) and regions in repetitive elements
(intracisternal A-particles and major satellite DNAs; average:
7.0%), which are known to be associated with H3K9me3 (ref. 23).
These results indicated that the Xist promoter region was
hypomethylated in sperm, in agreement with Xp-Xist being
expressed in early embryogenesis.
Preparing sufﬁcient numbers of embryos or oocytes for ChIP
combined with deep sequencing (ChIP-seq) analysis is proble-
matic. Some ChIP-qPCR methods requiring small samples have
been reported24; however, most of these studies are based on a
cross-linking ChIP method, in which the ChIP efﬁciency is lower
than that of native ChIP methods25. Thus, we developed a new
native ChIP method combined with a Taqman qPCR system for
quantiﬁcation of transcription in single cells (termed eChIP-
qPCR) and focused on three loci at Xist 50-regions containing the
major promoter and repeat A, which is essential for establishment
of iXCI26 (Fig. 4b). We ﬁrst tested whether the quantiﬁcation
system was biased by using diluted DNA from bulk ES cells. The
results of ChIP-qPCR from pre-ampliﬁed DNA were comparable
to those obtained without pre-ampliﬁcation (Supplementary
Fig. 8).
Using this system, we examined H3K9me3 states at three Xist
regions and at Gapdh promoter regions (as a negative control) in
PEs at the four-cell stage. We ﬁrst investigated whether our eChIP
method was efﬁcient by examining major satellite repeats that
have been identiﬁed as H3K9me3-rich regions in preimplantation
embryos23. Consistent with a previous report, H3K9me3 was
highly enriched at major satellite regions (Fig. 4c). The three Xist
regions were also highly methylated compared with the Gapdh
promoter region, as follows: 50-R, 3.7-fold upregulated; XP,
9.8-fold upregulated; RA, 12.1-fold upregulated; (Fig. 4d).
As Fig. 2a showed Xm-Xist spontaneous derepression at the
morula stage, we next investigated whether H3K9me3 levels at
the Xist promoter region were low at this stage. eChIP-aPCR
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reduced compared with that at the Gapdh promoter region in the
four-cell stage (50-R, 0.83-fold upregulated; XP, 2.85-fold
upregulated; RA, 4.8-fold upregulated; Fig. 4e). These results
suggested that demethylation at the promoter region was essential
for Xm-Xist derepression.
We then asked whether Xist promoter demethylation was
involved in the Xm-Xist derepression observed in Kdm4b-PEs at
the four-cell stage. The H3K9me3 levels at major satellite regions
in Kdm4b-PEs were signiﬁcantly reduced compared with those in
Egfp-PEs (Kdm4b-PEs: 9.74% versus Egfp-PEs: 24.63%, Po0.01,
Student’s t-tests; Fig. 4f). At three Xist regions, the H3K9me3
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reduced, as follows: 50-R, Kdm4b-PEs: 0.84% versus Egfp-PEs:
11.48%, Po0.05, Student’s t-tests; XP, Kdm4b-PEs: 3.13% versus
Egfp-PEs: 16.08%; Po0.04, Student’s t-tests; and RA, Kdm4b-PEs:
20.16% versus Egfp-PEs: 29.99%; Fig. 4g. Taken together, these
results demonstrated that H3K9me3 at the promoter region
protected Xm-Xist, preventing RNF12-mediated activation from
the four-cell stage. We concluded that silencing of Xm-Xist by
imprinting to establish iXCI involved H3K9me3.
Maternal repressive H3K9me3 mark is absent in ES cells.
Previous studies have shown that Xist is ectopically expressed in
embryos cloned from somatic and ES cells27,28. However, the
cause of aberrant Xist expression in cloned embryos remains
unknown. Given that high H3K9me3 levels at the promoter
region in PEs are lost during development (Fig. 4d,e), we
investigated whether the maternal repressive H3K9me3 mark was
lost in ES cells and whether Xist in ES cells was permissive against
RNF12 during oocyte-mediated reprogramming.
To test this possibility, we ﬁrst examined H3K9me3 states at
Xist regions in various types of male ES cells, using published
data29,30. The levels of H3K9me3 at Xist regions containing
promoters in TT2 and E14 ES cell lines were low compared with
those in positive control regions (Supplementary Fig. 9). ChIP-
seq analysis revealed that although ectopic expression of KDM4B
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(Supplementary Fig. 10a–d), it did not alter H3K9me3 levels at
Xist regions. Moreover, these levels were low compared with
those of a known H3K9me3-rich region (Supplementary
Fig. 10e)16. Furthermore, the expression of Xist in cloned
embryos was also not affected by ectopic expression of KDM4B
(Supplementary Fig. 10f). These results indicated that the
maternal repressive H3K9me3 mark was lost.
To establish whether RNF12 is involved in Xist activation
during oocyte-mediated reprogramming, oocytes treated with
si-Rnf12 were used as recipients for nuclear transfer
(Supplementary Fig. 10g). At the four-cell stage, derepression of
Xist transcription in ES-cloned embryos depended on RNF12
(450% repression in si-Rnf12 group; Supplementary Fig. 10h).
Taken together, these data indicated that the intrinsic H3K9me3
mark, which was essential for repression of Xist by RNF12, was
lost during embryo development. This indicated that the primary
cause of aberrant Xist expression in cloned embryos was involved
in loss of intrinsic H3K9me3 at Xist regions.
Effects of iXCI disruption on FEs. The effects of Xm-Xist
derepression on postimplantation development remain unclear.
First, we asked whether ectopic Kdm4b expression caused Xm-
Xist derepression in FEs. Kdm4b-FEs developed into blastocysts
with high efﬁciency (480% of two-cell embryos; Supplementary
Table 6). At the 96-h blastocyst stage, Xist transcription was
derepressed in male Kdm4b-FEs, while Pgk1 and Plac1 levels were
reduced to o13% of those observed in controls (Supplementary
Fig. 11a). In female Kdm4b-FEs, FISH analysis revealed that there
were cells with Xist biallelic expression (Supplementary Fig. 11b).
Although the expression level was slightly elevated (1.3-fold),
X-linked genes were also signiﬁcantly repressed in female Kdm4b-
FEs (Supplementary Fig. 11c). These results showed that ectopic
Xm-Xist derepression caused X-linked gene silencing and elim-
ination of iXCI.
To test the effects of iXCI disruption on postimplantation
development, we conducted in vivo transplantation experiments.
Interestingly, our results demonstrated that XCI on Xm during
preimplantation did not affect developmental competence to term
(Kdm4b-FEs: 63.2% versus Egfp-FEs: 53.1%; Supplementary
Fig. 11d,e), suggesting that aberrant XCI in preimplantation
embryos was restored during postimplantation development,
probably through an automatic counting function. These results
were consistent with the observation that the developmental
competency of embryonic cloned embryos was high, despite the
ectopic expression of Xist and the occurrence of global XCI
(Supplementary Fig. 12)28,31.
Loss of XCI impairs the postimplantation development of PEs.
It is still unknown whether the embryonic lethality observed
immediately after implantation in the majority of PEs (around
70–80%) can be attributed to the loss of dysregulation of X-linked
genes or to loss of expression of autosomal paternally imprinted
genes. Figure 2 showed that the percentage of Xist-positive cells in
Kdm4b-PEs was signiﬁcantly higher than that in Egfp-PEs. Thus,
we reasoned that Kdm4b-PEs would be suitable for studying this
long-standing question.
We ﬁrst performed a detailed analysis of Xm-XCI states in
Kdm4b-PEs using IF against H3K27me3 and CDX2, a marker of
the trophectoderm, in combination with Xist FISH, at the
blastocyst stage. This analysis revealed that Xist-positive cells
were signiﬁcantly increased in the trophectoderm of Kdm4b-PEs,
although the ratio of H3K27me3-positive cells was comparable to
that of Egfp-PEs (Fig. 5a–c and Supplementary Table 7).
However, no signiﬁcant difference was observed in the inner cell
mass between groups (Fig. 5a–c and Supplementary Table 7),
indicating that loss of H3K9me3 in the maternal genome led to
establishment of Xm-XCI as an imprinted Xp-XCI.
Next, we carried out transcriptome analysis in Egfp-PEs,
Kdm4b-PEs and FEs using microarray. Clustering analysis based
on gene expression patterns showed that all three groups could be
distinguished clearly from each other (Supplementary Fig. 13a).
Comparison of transcripts between Egfp-PEs and Kdm4b-PEs
identiﬁed transcripts that were signiﬁcantly differentially
expressed: 671 transcripts were upregulated and 711 transcripts
were downregulated (Po0.05, Student’s t-test and41.5-fold
changes in Kdm4b-PEs). Chromosome distribution analysis
showed that upregulated transcripts in Kdm4b-PEs were
distributed across various chromosomes (2.33–7.23%;
Supplementary Fig. 13b). However, downregulated transcripts
in Kdm4b-PEs were mostly concentrated on the X chromosome,
which particularly involved the Xlr and Magea families (10.26%;
Supplementary Fig. 13c–e).
Comparison of the imprinted genes between Egfp- and Kdm4b-
PEs revealed that only six genes were signiﬁcantly differentially
expressed (paternally expressed genes: Impact and Fthl17;
maternally expressed genes: Gnas, H13, Xlr3b and Xlr4b;
Fig. 5d). Clustering analysis based on the expression of imprinted
genes showed that the expression levels in Kdm4b-PEs were
similar to those in Egfp-PEs rather than to those of biparental
embryos (Fig. 5d). Thus, H3K9me3 demethylation does not result
in restoration of expression states in paternally expressed genes.
We conducted in vivo transplantation experiments using
Kdm4b-PEs. Surprisingly, at E6.5, the developmental rates of
Kdm4b-PEs were markedly increased compared with those of
Egfp-PEs (Kdm4b-PEs: 90% versus Egfp-PEs: 35%; Po0.001,
Fisher’s exact test; Fig. 5e,f). At E9.5, although the stages of the
recovered embryos varied, Kdm4b-PEs retained a signiﬁcantly
higher developmental ability compared with controls (Kdm4b-
PEs: 64.3% versus Egfp-PEs: 31.9%; Po0.002, Fisher’s exact test;
Fig. 5e,f).
However, we did not rule out the possibility that the signiﬁcant
improvement in Kdm4b-PE development resulted from restora-
tion of the expression levels of some imprinted genes. To
determine whether the improvement in developmental compe-
tency could be attributed to the gain of XCI, we constructed
Kdm4bþsi-Rnf12-PEs. In Kdm4b-PEs with si-Rnf12 at the
blastocyst stage, Xist expression analysis by FISH revealed that
Xist cloud signals in control Kdm4b-PEs were present in 51.9% of
cells, while those in Rnf12-knockdown Kdm4b-PEs were present
in only 10% of cells, and most of the signals were pinpoint rather
than cloud (Fig. 5g,h and Supplementary Table 8).
qPCR analysis showed that although Xist signals were
signiﬁcantly reduced in Kdm4b-PEs with si-Rnf12 (12.5% of the
control on average), the expression levels of Impact, H13 and
Gnas, which are expressed in response to ectopic Kdm4b
expression (Fig. 5d), did not change when compared with those
of controls (Fig. 5i). We further demonstrated that RNF12
depletion did not affect Tsix and Sfmbt2 expression levels in
Kdm4b-PEs (Fig. 5i). These results clearly indicated that RNF12
depletion led to Xist downregulation in Kdm4b-PEs, without
altering the features of PEs.
Finally, in vivo transplantation experiments demonstrated that
Xist repression by RNF12 depletion signiﬁcantly inhibited
developmental competency at E6.5 in Kdm4b-PEs (Kdm4bþ
si-control: 84.2% versus Kdm4bþsi-Rnf12: 23.5%; Po0.0006,
Fisher’s exact test; Fig. 5j,k). Taken together, these results
demonstrated that the developmental defects seen in PEs
immediately after implantation could be attributed to the lack
of XCI, but not to loss of expression of paternally expressed
genes.
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In this study, we demonstrated that maternal imprinting of Xm,
which protected against Xist activation by RNF12 in the
preimplantation stages, was mediated by H3K9me3.
Xm-Xist imprints are established during oogenesis and
autosomal imprinting also occur in the phases6,10. In many
imprinted genes, DNA methylation at the promoter regions is the
primary regulator and H3K9me3 modiﬁcations overlap with
these regions32. However, it is not clear why Xm-Xist regions are
targeted by H3K9me3, but not by DNA methylation. One of the
possibilities is that during primordial germ cell development, Xist
must be silenced to activate the inactivated allele before inducing
the expression of Dnmt3a/3l, which encodes a de novo DNA
methyltransferase that is activated during oogenesis33. Consistent
with this concept, Xist repression begins in primordial germ cells
at E10.5 (ref. 34). Thus, comparison of H3K9me3 states at
promoter regions in non-growing oocytes with those in growing
oocytes will greatly facilitate understanding of the molecular
mechanisms of iXCI.
We found that Kdm4b-, EgfpþTSA- and Kdm4bþTSA-PEs
did not show complete XCI at the blastocyst stage as compared
with female FEs. These results suggested that other repressive
marks were imposed on Xm to silence Xm-Xist expression.
Alternatively, removal of H3K9me3 may be incomplete because
demethylation at RA regions was mild (Fig. 4g). However, it is
not clear why RA regions show resistance against demethylation
by KDM4B. As suggested in a previous study, this mechanism
may be related to the three-dimensional structure of the A-repeat,
which has been reported to constitute stable regions in the
Xist transcript35. Further studies using ChIP-seq and/or
chromatin-conformation capture sequencing technologies in
preimplantation embryos are required for comprehensive
understanding of Xist regulation.
In ES cells, RNF12 induces Xist expression through degrada-
tion of REX1, which is required for suppression of Tsix36.
Interestingly, we did not detect Tsix expression from the morula
to the blastocyst stages in in vitro-fertilized (IVF) embryos,
implying that the molecular mechanism of RNF12-mediated Xist
activation differs between imprinted and randomly induced XCI.
It is not known whether the role of RNF12 in Xist activation
during the preimplantation stages was direct or indirect. Recent
RNF12 studies reported the speciﬁc binding of RNF12 to Smad7
in mouse ES cells37, suggesting that signalling via transforming
growth factor-b family members may be associated with
imprinted Xist activation.
In this study, we revealed the molecular mechanisms under-
lying imprinting of XCI and demonstrated the role of XCI in
various types of embryo development in mice. Recent studies
using somatic- and ES-cloned embryos revealed that aberrant Xist
reprogramming is a major cause of developmental failure in
cloned embryos27,28. We found that RNF12 was highly expressed
in oocytes compared with somatic and ES cells (480-fold).
Moreover, we showed that H3K9me3 levels at Xist promoter
regions were low in ES cells and that Xist expression in ES-cloned
embryos depended on RNF12. These data provided the ﬁrst
evidence that RNF12 inhibited developmental reprogramming.
Therefore, the use of RNF12-depleted oocytes as recipient cells
would improve cloning efﬁciency. However, Xist activation in
cloned embryos may be induced by factors other than RNF12, as
supported by the observation that Xist was still expressed at
B40% of control levels, even after marked depletion of RNF12.
Consistent with this notion, a recent study has demonstrated that
RNF12 is dispensable for random XCI in vivo38.
Xm-Xist derepression from the four-cell stage could rescue
developmental defects in PEs. This ﬁnding demonstrated that the
primary cause of developmental failure immediately after
implantation was a lack of XCI, but not a lack of expression of
paternally imprinted genes. We also tested whether Kdm4b-PEs
could extend development; however, we did not observe extended
Kdm4b-PE development after E9.5, implying that expression of
paternally imprinted genes is required for subsequent develop-
ment in PEs11,12.
Our data resolved several long-standing unanswered questions
about XCI during preimplantation in various types of embryos
(Supplementary Fig. 14). Moreover, given that injection of Kdm4b
mRNA into PEs improved their developmental ability, genetic
mutation leading to embryonic lethality could be rescued by
transient expression of epigenomic modiﬁers during preimplan-
tation phases.
Methods
Embryo manipulations. All mice were maintained and used in accordance with
the Guidelines for the Care and Use of Laboratory Animals of the Japanese
Association for Laboratory Animal Science and the National Research Institute for
Child Health and Development (NRICHD) of Japan. All animal experiments were
performed according to protocols approved by the Institutional Animal Care and
Use Committee of the NRICHD (Permit Number: A2006-009).
Adult female B6D2F1 mice were purchased from Clea Japan (Tokyo, Japan)
and oocytes were collected following standard methods27. PEs were generated
using Ca-free M16 medium containing 8mM SrCl2 and Cytochalasin B
(5mgml 1) (Sigma-Aldrich, St Louis, MO, USA), and cultured KSOM (EMD
Millipore, Darmstadt, Germany). Injection experiments (mRNA, short interfering
RNA (siRNA) and nuclear transfer) were conducted using a Prime Tech Piezo
drive (Sutter Instrument Company, Novato, CA, USA). To produce cloned
embryos, nuclear-transferred oocytes were parthenogentically activated.
Manipulated embryos were cultured to the developmental stages, as follows: 4-cell,
48h; morula, 72h; and blastocyst, 96 and 120h after parthenogenetic activation or
ICSI, respectively. All embryos were cultured at 37C in KSOM in an atmosphere
containing 5% CO2. In the TSA experiment, the embryos were cultured for 24h in
activation and culture media containing 50nM TSA (Sigma-Aldrich). IVF
fertilization and nuclear transfer were performed following published procedures27.
To determine the effects of ectopic KDM4B expression on Xist expression in cloned
embryos, doxycycline was added to ES cell culture and KSOM medium to a ﬁnal
concentration of 2mgml 1. Pseudopregnant ICR mice (Clea Japan) were used as
embryo recipients. At E6.5, E9.5 and E18.5, the embryos were recovered from the
uterus.
In vitro mRNA synthesis. The coding region of Kdm3a was ampliﬁed from mouse
testis complementary DNA using PCR with KOD-Plus-Neo DNA polymerase
(Toyobo, Osaka, Japan). Forward and reverse primers contained T7 promoter and
poly(T)120 sequences, respectively. A step-down PCR ampliﬁcation method was
used, following the manufacturer’s instructions (Toyobo). Poly(A)-containing PCR
products were subjected to in vitro transcription using a mMESSAGE mMA-
CHINE T7 ULTRA Kit (Life Technologies, Carlsbad, CA, USA), following the
manufacturer’s instructions. To generate a Kdm4b DNA template for in vitro
transcription, pCMV-SPORT6 containing the full-length Kdm4b mRNA was used
as the PCR template (DNAFORM, Kanagawa, Japan, Clone ID 3490671). Egfp
cDNA was cloned using the pGEM-T Easy Vector System (Promega, Madison, WI,
USA) and transcribed in vitro using the mMESSAGE mMACHINE T7 ULTRA Kit
(Life Technologies) following the manufacturer’s instructions. The concentrations
of the mRNAs were adjusted to 150ngml 1 (Egfp), 550ngml 1 (Kdm3a),
or 450ngml 1 (Kdm4b) to maintain a constant number of injected mRNA
molecules. The primer sequences used for generating the templates for in vitro
transcription are shown in Supplementary Table 9.
Rnf12 knockdown. siRNA targeting Rnf12 (si-Rnf12 sense 50-GAAGUCAAAUG
GAUCGCUUTT-30 A and antisense 50-AAAGCGAUCCAUUUGACUUCTG-30
GC, and the negative control siRNA (si-control: 4390846) were purchased from
Life Technologies. The ﬁnal concentration of each siRNA was 50ngml 1.T h e
siRNA was injected into MII oocytes using the Piezo drive and then incubated for
6–7h in KSOM medium at 37C in an atmosphere containing 5% CO2 before
mRNA injection. For the NT experiment using Rnf12-knockdown oocytes, oocytes
were incubated for 5–6h after siRNA injection, and NT was then conducted and
activated as described above.
Immunoﬂuorescence. Oocytes injected with mRNAs were subjected to ICSI. After
10–11h, the zygotes were ﬁxed with 2% paraformaldehyde (PFA) in PBS con-
taining 0.1% polyvinyl alcohol (PBS-PVA) for 15min at room temperature (RT).
Zygotes were then permeabilized using 0.2% Triton X-100 in PBS-PVA for 15min
at RT and blocked in 1% BSA in PBS-PVA for 1h at RT. The primary antibodies
used in the assay were as follows: anti-H3K9me3 (ab8898, 1:500 dilution, Abcam,
Cambridge, UK), anti-H3K9me2 (ab1220, 1:500, Abcam) and anti-H3K27me3
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blocking solution (PBS-PVA containing 1% BSA) and the embryos were incubated
overnight at 4C. After washing in blocking solution, the embryos were incubated
for 1h at RT with Alexa Flour 634- or 546-conjugated anti-mouse or anti-rabbit
IgG secondary antibodies (1:500, Life Technologies). After the embryos were
washed, the nuclei were stained with 1mgml 1 40,6-diamidino-2-phenylindole and
the embryos were placed on a glass slide and observed with a LSM510 laser
scanning confocal microscope (Carl Zeiss, Oberkochen, Germany). Signal
intensities of maternal and paternal pronuclei were calculated using NIH ImageJ
software (http://rsb.info.nih.gov/ij/).
In Rnf12-knockdown experiments, one-cell and four-cell PEs were ﬁxed at
10–11h (18–19h after siRNA injection) and 48h after activation, respectively.
Anti-RNF12 (1:500, Abnova, Taipei, Taiwan) and Alexa Fluor 488-conjugated
anti-mouse IgG antibodies (1:500, Life Technologies) were used as the primary and
secondary antibodies, respectively. Rnf12-knockdown and negative-control PEs
were observed under the same conditions, to assess knockdown efﬁciency. Signal
intensities were calculated using ImageJ software.
Fluorescent in situ hybridization. The zona pellucida of embryos was removed
using acid Tyrode solution (Sigma-Aldrich) and then ﬁxed and permeabilized with
2% PFA-PVA containing 0.25% Triton X-100 for 10min on ice. The samples were
placed on glass slides, evaporated to dryness, dehydrated sequentially in 70 and
100% ethanol and then air-dried. Hybridization buffer containing an Xist probe
(provided by T. Sado) was prepared using a Nick Translation Kit (Abbott, Abbott
Park, IL, USA) and Cy3-dUTP (GE Healthcare Life Sciences, Fairﬁeld, CT, USA)
and was then applied to the slides. The slides were then incubated and washed as
previously described26. Fluorescence was visualized using the LSM510.
IF combined with FISH. The zona pellucida of embryos was removed using acid
Tyrode solution (Sigma-Aldrich) and ﬁxed with 2% PFA-PVA for 15min at RT in
four-well dishes. The ﬁxed samples were permeabilized with 0.5% Triton X-100 in
PBS-PVA for 20min on ice. After washing with PBS-PVA, the samples were
blocked in 1% BSA-PBS-PVA containing 1.3Uml 1 RNaseOUT (Life Technol-
ogies) for 30min at RT. After washing, the embryos were incubated with primary
antibodies (anti-CDX2 (BioGenex, San Ramon, CA, USA), diluted 1:30 and anti-
H3K27me3 diluted 1:150 in blocking buffer containing 1.3Uml 1 RNaseOUT)
for 1h at RT. Secondary antibody reactions were performed as described above.
The samples were placed on glass slides, evaporated to dryness, dehydrated
sequentially in 70 and 100% ethanol and air dried. The samples were then analysed
by FISH according to the procedures described above.
Analysis of IF combined with FISH data. Xist cloud signals detected in three-
dimensional images using Z-sections of the LSM Image Browser (Carl Zeiss) were
judged as positive. Only cells that did not overlap at interphase were used in the
analysis. Biallelic expression was deﬁned as cells with two Xist cloud spots.
Statistical analysis was performed using Fisher’s exact test.
Gene expression analysis. Total RNA was extracted using an RNeasy Micro Kit
(Qiagen, Venlo, The Netherlands) and treated with DNase following the manu-
facturer’s instructions. mRNAs were reverse transcribed using an oligo(dT) primer
and SuperScriptIII Reverse Transcriptase (Life Technologies). For quantitative gene
expression analysis with high speciﬁcity, TaqMan probes (Life Technologies) were
used in all assays. In four-cell stage embryos, Xist was assayed in triplicate and only
the samples that were detected in two or three replicates were judged as positive. In
morulae and blastocysts, expression of target genes was assayed in duplicate. Gapdh
was used as the internal control in the four-cell-stage assays and Rnf12 was used in
the time-lapse assays. Gapdh and Actb (encoding b-actin) were used as internal
controls at the morula and blastocyst stages. For normalization of qPCR analysis
(Fig. 2b,g), the expression levels of all embryos were normalized to the average
expression levels of Egfp-PEs. The TaqMan probes and primer sets used in this
study are shown in Supplementary Table 8.
Generation of Kdm4b-inducible ES cell lines and ES cell culture. The XhoI- and
ClaI-linearized pGEM-IRES-EGFP plasmids were inserted into the cognate sites of
pPB-CAG-EBNX (provided by A. Bradley) to generate pPB-CAG-IRES-EGFP. A
Tet3G fragment with BglII and XhoI cleavage sites was ampliﬁed from a pEF1a-
Tet3G template (Clontech Laboratories, Mountain View, CA, USA) using PCR and
inserted into pPB-CAG-IRES-EGFP, generating the vector pPB-CAG-Tet3G-IRES-
EGFP. The XhoI and BamHI cleavage sites in pPB-UbC (provided by A. Bradley)
were replaced with the p-TRE3G multiple cloning sites (Clontech). The Kdm4b
coding sequence, with terminal ClaI and BamHI cleavage sites, was ampliﬁed by
PCR and inserted into the corresponding sites of pPB-TRE3G, yielding pPB-TRE-
Kdm4b.
The NCH.4.6 male mouse ES cell line (C57B6/N C57B6/N), which had a
normal karyotype, was electroporated with pPB-TRE-Kdm4b, pPB-CAG-Tet3G-
IRES-EGFP and pCMV-hyPBase (provided by A. Bradley). All ES cells used in this
study were cultured in knockout DMEM (Life Technologies) containing
recombinant human leukemia inhibitory factor culture supernatant for mouse ES
cell culture (Wako Pure Chemical Industries, Ltd, Osaka, Japan), as well as
GlutaMAX, 2-mercaptoethanol, non-essential amino acids and 15% KSR (all from
Life Technologies). Doxycycline (2mgml 1; Sigma-Aldrich) was added to ES cell
culture medium to induce ectopic KDM4B expression.
Western blotting. Cells were extracted using a stock lysis buffer containing 1M
Tris–HCl, 5M NaCl, 10% Triton-X and protease inhibitors, and were subjected to
e-PAGEL (ATTO, Amherst, NY, USA) electrophoresis. The membranes were
washed in TBS containing 0.1% Tween 20 (TBS-T) and blocked in 5% skim milk
in TBS-T for 1h. The membranes were incubated with anti-KDM4B antibodies
(1:500 dilution; Active Motif, Carlsbad, CA, USA) overnight at 4C, washed and
incubated with a rabbit horseradish peroxidase-conjugated secondary antibody
(1:5,000 dilution; Sigma-Aldrich) for 1h at RT. Immunoblottings were visualized
using SuperSignal chemiluminescent substrate (Thermo Scientiﬁc, Waltham, MA,
USA) and an ImageQuant LAS4000 system (GE Healthcare). After capturing the
images, the membranes were washed with WB Stripping Buffer (Nacalai Tesque,
Kyoto, Japan) for 10min, washed with TBS-T and incubated with an anti-b-actin
antibody conjugated to ﬂuorescein isothiocyanate (1:2,000 dilution; Sigma-Aldrich)
for 1h at RT.
ChIP analysis of K4B-ES cells. Trypsinized feeder-free ES cells (2 107) were
collected and ﬁxed with 1% formaldehyde. The cells were resuspended in SDS lysis
buffer (ChIP Reagent, Nippon Gene Co., Ltd.) and the lysate was sonicated to
fragment chromatin using a S220 Focused-ultrasonicator (Covaris, Woburn, MA,
USA). The chromatin was puriﬁed by centrifugation and immunoprecipitated with
Protein A-beads (Veritas Life Sciences, Ribeira ˜o Preto, Brazil) conjugated to
anti-H3K9me3 antibodies (Abcam: ab8898) or rabbit IgG (Abcam: ab37415) in
Buffer A with protease inhibitor (LowCell ChIP kit, Diagenode, Denville, NJ, USA)
overnight at 4C. The chromatin beads were washed with Buffers A and C
(LowCell ChIP kit). After washing, the chromatin beads were incubated in ChIP
direct elution buffer (ChIP Reagent) for 6h at 65C, following incubation with 2ml
proteinase K (20mg0ml 1) for 2h at 55C. The DNA immunoprecipitated from
the supernatant was puriﬁed using Agencourt AMPure XP beads (Beckman
Coulter, Inc., Pasadena, CA, USA) according to the manufacturer’s instructions.
ChIP combined with deep sequencing. ChIP-Seq libraries were prepared using
the NEBNext ChIP-Seq Library Prep Master Mix Set and Multiplex Oligos from
Illumina (New England BioLabs Inc., Ipswich, MA, USA) according to the
manufacturer’s instructions. Ten nanograms of ChIP or input DNA was subjected
to end repair, dA-tailing and adaptor ligation, and ampliﬁed using nine cycles
of PCR. The ﬁnal library size was checked using a 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA, USA). After the concentration of each library
was determined using qPCR with a KAPA Library Quantiﬁcation Kit-Illumina/
Universal system (KK4824, Kapa Biosystems, Wilmington, MA, USA), the libraries
were sequenced using the HiSeq 1000 sequencing system (Illumina, San Diego, CA,
USA) to generate 100bp 2 paired-end data.
ChIP-seq data analysis. Reads from each sample were ﬁrst trimmed by removing
adapter sequences and low-quality bases at ends using Trimmomatic 0.22
(http://www.usadellab.org/cms/index.php?page=trimmomatic). Approximately
115 million reads for each of the ChIP and input libraries were aligned to the
mouse reference genome (mm10:http://genome.ucsc.edu/cgi-bin/hgGateway) using
the Burrows-Wheeler Aligner 0.6.2. Uniquely mapped reads were selected using a
custom script, converted from SAM to BAM format using SAMtools 0.1.18 and
processed using Picard 1.83 to mark PCR duplicates. Reads with a mapping quality
of o20 were removed using SAMtools 0.1.18. The resulting BAM ﬁles (a pair of
ﬁles for ChIP and input libraries) were visualized using the Integrative Genomics
Viewer (http://www.broadinstitute.org/igv/) and subjected to peak detection using
the MACS algorithm implemented in Avadis NGS software (Agilent). In scatter
plot analysis using 1 and 15 K4B-ES cell lines, the numbers of mapped reads were
counted for 10,000-bp windows (with a sliding size of 5,000bp). To adjust for
differences in total amount of reads, the number of mapped reads in each window
was transformed into reads per million format. Calculation methods are available
on request.
ChIP-qPCR analysis of sperm. Sperm were obtained from BDF1 mice aged 9–12
weeks. Preparation of sperm chromatin was performed according to published
protocols with modiﬁcations39,40. For each native ChIP experiment, 5 107 sperm
were used. Sperm were washed twice with PBS. The pellet was suspended in PBS
containing 0.5% Triton-X, 10mM dithiothreitol (DTT) and protease inhibitor
(Diagenode), and incubated on ice for 1.5h. After washing with PBS, pelleted
sperm nuclei were suspended in 400ml PBS containing 1mM CaCl2 and 1mM
DTT, and incubated for 5min at 37C. After incubation, 1ml( 2 106 gel units per
ml) micrococcal nuclease (New England BioLabs) was added to the nuclei, which
were then incubated for 5min at 37C. EDTA was added to a concentration of
0.5mM and solubilized chromatin was clariﬁed by centrifugation for 15min at
15,000 r.p.m. at 4C. The pellets were suspended in PBS containing CaCl2 and
DTT (at the same concentrations as used above), and treated again with
micrococcal nuclease. To examine whether H3K9me3-modiﬁed nucleosomes were
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were subjected to western blotting using anti-H3K9me3 antibodies (ab8898;
1:1,000), as described above.
Chromatin was incubated with Protein A beads conjugated to anti-H3K9me3
antibodies (ab8898) or rabbit IgG (ab37415) overnight at 4C in ChIP buffer
(40mM Tris–HCl, pH 7.5, 1M NaCl and 10mM EDTA). Pelleted beads were
washed twice with Buffer 1 (50mM Tris–HCl, pH 7.5, 500mM NaCl and 10mM
EDTA) and Buffer 2 (50mM Tris-HCL, pH 7.5, 300mM NaCl and 10mM EDTA).
The pelleted beads were suspended in ChIP direct elution buffer and incubated
with proteinase K for 2h at 37C. The immunoprecipitated DNA was then puriﬁed
using Agencourt AMpure XP beads.
ChIP-qPCR analysis was performed according to published methods using
SYBR Green39. The sequences of each primer set are listed in Supplementary
Table 9.
eChIP-quantitative qPCR. The zona pellucidae of the embryos were removed by
acid Tyrode’s solution and washed in PBS containing 0.1% PVA. The embryos
were suspended in PBS containing 0.5% Triton-X, 0.5mM DTT and protease
inhibitor, and incubated on ice for 30min. After incubation, 1mM CaCl2 was
added to the buffer and samples were incubated for 5min at 37C. After
incubation, 0.5ml( 2 106 gel units per ml) micrococcal nuclease (New England
BioLabs) was added to the nuclei, which were then incubated for 5min at 37C.
EDTA was added to a concentration of 0.5mM and solubilized chromatin was
clariﬁed by centrifugation at 15,000 r.p.m. for 15min at 4C. The same procedures
were repeated one more time. Chromatin was incubated with Protein A beads
conjugated to anti-H3K9me3 antibodies (ab8898) or rabbit IgG (ab37415), pre-
pared as described above, overnight at 4C in ChIP buffer (40mM Tris–HCL, pH
7.5, 1M NaCl and 10mM EDTA). Pelleted beads were washed twice with Buffer 1
(50mM Tris–HCL, pH 7.5, 500mM NaCl and 10mM EDTA) and then with Buffer
2 (50mM Tris–HCL, pH 7.5, 300mM NaCl and 10mM EDTA). The pelleted beads
were then suspended in ChIP direct elution buffer and incubated with proteinase K
for 2h at 55C. The immunoprecipitated DNA was then puriﬁed using Agencourt
AMpure XP beads.
Eluted DNA (20ml) was divided into two aliquots; one (4ml) was used for a
SYBR Green assay targeting a major satellite and the other (16ml) was subjected to
pre-ampliﬁcation using a Single Cell-to-CT kit (Ambion, Austin, TX, USA)
according to the manufacturer’s instructions. The number of PCR cycles at the
pre-ampliﬁcation step was 20. The primer and probe sequences used are shown in
Supplementary Table 9.
Microarray analysis. Five Egfp-PE, Kdm4b-PE and IVF blastocysts (120h) were
lysed using ISOGEN (Nippongene) and RNA was extracted by phenol–chloroform
and isopropanol precipitation. cDNA was synthesized using the Ovation RNA
Ampliﬁcation System V2 kit (NuGEN, West Cumbria, UK) and hybridized with
SurePrint G3 Mouse GE 8x60K Microarray (Agilent Technologies). Analysis was
conducted using GeneSpringV12.5 (Agilent Technologies). Transcripts were
considered to be expressed if raw values were 4100 and a ﬂag was present in at
least one of the groups.
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